Cartesian Therapeutics grants new hires stock options for 59,700 shares at USD 9.27 each
RNAC•Stock option grant to three new employees
Cartesian Therapeutics granted stock options covering 59,700 shares to three new employees under its 2018 employment inducement plan.
- Exercise price set at USD 9.27 per share, matching the Nasdaq closing price on Sept. 4, 2026.
- Vesting starts with 25% on Sept. 4, 2027, then monthly installments, reaching full vesting on Sept. 4, 2030.
- The options carry a 10-year term.
